Published in
American Association for the Advancement of Science, Science Translational Medicine, 575(13), 2021
DOI: 10.1126/scitranslmed.aba6110
Links
Tools
Mitochondrial metabolic reprogramming controls the induction of immunogenic cell death and efficacy of chemotherapy in bladder cancer
Journal article published in 2021 by
Bianca Oresta 
,
Chiara Pozzi ,
Daniele Braga ,
Rodolfo Hurle,
Massimo Lazzeri,
Piergiuseppe Colombo,
Nicola Frego,
Marco Erreni ,
Cristina Faccani,
Grazia Elefante ,
Matteo Barcella ,
Giorgio Guazzoni,
Maria Rescigno
,
Chiara Pozzi ,
Daniele Braga ,
Rodolfo Hurle,
Massimo Lazzeri,
Piergiuseppe Colombo,
Nicola Frego,
Marco Erreni ,
Cristina Faccani,
Grazia Elefante ,
Matteo Barcella ,
Giorgio Guazzoni,
Maria Rescigno
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
Immunogenic cell death induced through metabolic reprogramming by intravesical chemotherapy in bladder cancer is associated with treatment success.